ArticleFrontiers in immunology2026
RAS mutation status and immune microenvironment define distinct prognostic landscapes and predict chemotherapy benefit in pMMR colorectal cancer.
Shigang Wu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.